Trial Profile
A Proof-of-Concept, Multicenter, Randomized, Double-Blind, Parallel Study of Naltrexone Sustained-Release (SR) and/or Fluoxetine Therapy in the Treatment of Subjects With Obsessive-Compulsive Disorder (OCD).
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2012
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary) ; Naltrexone (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- 12 Feb 2010 Actual patient number (8) added as reported by ClinicalTrials.gov.
- 11 Oct 2008 New trial record.